Eli Lilly & Company

Overview

Date Founded

1876

Type of Company

Public

Employees (Worldwide)

33.6K

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Website

http://www.lilly.com

Contact Data

Trying to get in touch with decision makers at Eli Lilly & Company? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

In The News

PR Newswire

December 2, 2020

Global Conventional and Alternative Pain Treatment Markets Report 2020-2025 with Profiles of Abbott Laboratories, Baxter International, Eli Lilly & Co., GlaxoSmithKline, and Johnson & Johnson

PR Newswire

December 2, 2020

Life-Saving Insulin Now Available at Free or No Cost to People Living in Stanislaus and Merced Counties; Partnership Between Legacy Health Endowment, Eli Lilly and Company, and Boies' Medical Center Pharmacy Guarantees Lower-Cost Access

Nasdaq

December 2, 2020

Lilly announces 650,000 additional doses of neutralizing antibody bamlanivimab (LY-CoV555) purchased by U.S. government to treat COVID-19

GlobeNewswire

December 1, 2020

Dental Turbine Market Research Report by Product Type, by Turbine Speed, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

PR Newswire

December 1, 2020

Diadem Names Dr. Tamas Bartfai Chair of Its Medical Advisory Board; -Dr. Bartfai Brings Broad Academic and Pharma Industry Experience to Medical Advisory Board Comprised of Distinguished Alzheimer's Disease Researchers and Opinion Leaders-

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

Executives & Employees

Dave Ricks

Chairman & Chief Executive Officer

Joshua L. Smiley

Senior Vice President & Chief Financial Officer

Anat Hakim

Senior Vice President, General Counsel & Secretary

Wolfgang Glaesner

Chief Scientific Officer

Daniel M. Skovronsky

Senior Vice President & Chief Scientific Officer

Patrik Jonsson

Chief Customer Officer

Ilya Yuffa

Senior Vice President & President, Lilly Bio-Medicines

Alfonso Zulueta

Senior Vice President & President, Lilly International

Stephen Fry

Senior Vice President, Human Resources & Diversity

Anne E. White

Senior Vice President & President, Lilly Oncology

Board of Directors

Dave Ricks

Chairman & Chief Executive Officer at Eli Lilly & Company

Juan R. Luciano

President & Chief Executive Officer at Archer Daniels Midland Co.

William G. Kaelin, Jr.

Co-Founder at Tango Therapeutics, Inc.

Michael L. Eskew

Former Chairman & Chief Executive Officer at United Parcel Service of America, Inc.

Jack Tai

Senior Advisor at Southern Capital Group Pte Ltd.

Carolyn R. Bertozzi

Professor at Howard Hughes Medical Institute, Inc.

Karen M. Walker

Senior Vice President Chief Marketing Officer at Intel Corp.

Ralph Alvarez

Operating Partner at Advent International Corp.

Kathi P. Seifert

Senior Managing Director at Brock Capital Group LLC

Erik Fyrwald

Chief Executive Officer & Executive Director at Syngenta AG

Trending Organizations

Paths to Eli Lilly & Company

Potential Connections via
Relationship Science

You

Eli Lilly & Company

Owners & Shareholders

Details Hidden

Lilly Endowment, Inc.

Founded in 1937 by J.K. Lilly, Sr. and his sons J.K. Lilly, Jr. and Eli Lilly, the Lilly Endowment, Inc. is a private, non-profit philanthropic foundation located in Indianapolis, Indiana. The Lilly Endowment supports the causes of community development, education and religion

Details Hidden

PRIMECAP Management Co.

PRIMECAP Management aims to provide superior long-term investment results by utilizing fundamental research and bottom-up stock picking to construct portfolios. The firm looks for stocks that will outperform the market over a three to five-year horizon. PRIMECAP Management does not have a committee or small group that decides on whether or not to invest in an idea. Each portfolio manager makes an individual decision whether or not to invest in new ideas.

Details Hidden

Wellington Management Company LP

WMC relies on their extensive independent research and include portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has a number of different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. WMC’s portfolio management teams often include dedicated analysts who evaluate securities and other instruments for suitability based on the team’s investment approach. The firm supplements their internal research with external research from sources such as broker/dealers and third-party research firms. These sources typically provide data, research and analysis and may serve as a gauge of market consensus.

Recent Transactions

Details Hidden

Eli Lilly & Company purchases Dermira, Inc.

Details Hidden

Eddingpharm (Cayman), Inc. purchases Eli Lilly & Co. /Ceclor Manufacturing Facility from Eli Lilly & Company

Details Hidden

Eli Lilly & Company purchases Loxo Oncology, Inc.

Insider Transactions

Details Hidden

Melissa Stapleton Barnes

Details Hidden

Michael L. Eskew

Details Hidden

Erik Fyrwald

Transaction Advisors

Legal Advisor

Weil, Gotshal & Manges LLP

Advised onEli Lilly & Company purchases Elanco Tiergesundheit AG from Novartis AG

Legal Advisor

Latham & Watkins LLP

Advised onEli Lilly & Company purchases ImClone LLC

Legal Advisor

Dewey Ballantine LLP

Advised onEli Lilly & Company purchases ICOS Corporation

Legal Advisor

Raymond O. Gietz

Advised onEli Lilly & Company purchases Elanco Tiergesundheit AG from Novartis AG

Legal Advisor

Amy M. Rubin

Advised onEli Lilly & Company purchases Elanco Tiergesundheit AG from Novartis AG

Global Co-Chair, Mergers & Acquisitions Practice Group

M. Adel Aslani-Far

Advised onEli Lilly & Company purchases ImClone LLC

Advisors & Consultants

Legal Advisor

Bradd L. Williamson

Chair, Benefits & Compensation Practice at Latham & Watkins LLP

Legal Advisor

Charles F. Rule

Partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP

Legal Advisor

Andrew Forman

Partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP

Clients

United Therapeutics Corp.

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

OPKO Health, Inc.

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Melinta Therapeutics, Inc.

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.

Key Stats and Financials As of 2019

Market Capitalization

$141B

Total Enterprise Value

$137B

Earnings Per Share

$4.96

Revenue

$22.3B

Net Profit

$4.64B

EBITDAMargin

31.46%

Enterprise Value EBITDAOperating

19.36x

TEVNet Income

29.44x

Debt TEV

0.12x

Enterprise Value / Sales

6.12x

Total Equity

$2.7B

Total Debt

$15.9B

EBITDA

$7.02B

Three Year Compounded Annual Growth Rate Of Revenue

1.69%

Non-Profit Donations & Grants

$5,000 - $10K

2020

Saint Mary of the Woods College

$5,000 - $10K

2019

Kentucky Wesleyan College

$1M +

2019

United Way of Central Indiana, Inc.

Non-Profit Donations & Grants Received

$1.02M

12/31/2017

Bill & Melinda Gates Foundation

$501K

12/31/2016

Bill & Melinda Gates Foundation

Political Donations

$350

2014

Valerie J. Longhurst

$500

2014

Asa Hutchinson

$200

2014

F. Gary Simpson

Investments

Details Hidden

CureVac AG

CureVac AG engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.

Details Hidden

NextCure, Inc.

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Details Hidden

Cedilla Therapeutics, Inc.

Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D’Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA.

Investors

Details Hidden

Rajeev Dadoo

Partner at SR One Ltd.

Details Hidden

Frank Torti

Chairman-Vant Division at Roivant Sciences, Inc.

Details Hidden

Cristy Barnes

Investor at Avid Radiopharmaceuticals, Inc.

Suppliers

Computer Task Group, Inc. IT Consulting & Services | Buffalo, NY

CTG's mission is to provide IT services and solutions that add real business value to our customers while creating professional opportunities for our employees and value for our shareholders. CTG's Vision CTG's vision is to be recognized as a leading provider of value-added IT services and solutions in our selected markets. CTG's Values Integrity as the essential foundation of all business and personal interactions Individual initiative in personal and professional development A sense of personal pride in our work and satisfaction in serving our clients and our organization Clear, unambiguous understanding of our clients' needs and expectations Commitment to Quality Our commitment to quality ensures that we focus on continuous improvement, employ proven methodologies and best practices, and deliver services that meet client expectations and requirements. CTG is one of a few IT services companies using a ISO 9001-certified management system.

R.R. Donnelley & Sons Co. Computer Software | Chicago, IL

RR Donnelley (Nasdaq:RRD) is a global provider of integrated communications. The company works collaboratively with more than 60,000 customers worldwide to develop custom communications solutions that reduce costs, drive top line growth, enhance ROI and ensure compliance. Drawing on a range of proprietary and commercially available digital and conventional technologies deployed across four continents, the company employs a suite of leading Internet based capabilities and other resources to provide premedia, printing, logistics and business process outsourcing services to clients in virtually every private and public sector.

Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Competitors

Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Awards & Honors

Rank #141

2016

Fortune Magazine - Fortune 1000 Companies